Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
The debate between points and cash back is ongoing. Understand the benefits of each to determine which suits you best.
28,655 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A $500k annuity promises $2,950 a month for life, but a deeper look shows significant trade-offs in inflation, liquid...
A major fund’s exit from Ocular Therapeutix raises questions about timing, liquidity, and sector signals. This articl...
A new MLP income ETF employs a covered call overlay to lift yield beyond AMLP, drawing attention from income-focused ...
Binance Smart Chain transaction fees dropped to a fresh multi-month low, reinforcing a pattern that traders say could...
A Blackstone executive made revealing private credit comments, triggering investor debate on liquidity and risk. Anal...
A veteran market strategist argues Big Tech is underappreciated as earnings grow and capital spending remains durable...
In 2026, retirees consider monthly RMDs versus lump-sum year-end pulls as market volatility tests tax and cash-flow p...
A new period of market volatility and plan underfunding concerns spotlight four retirement mistakes that cost electri...
Bitcoin has fallen about 19% this year, prompting a closer look at three ETF types—spot, futures, and leveraged futur...
Automotive AI software leads the market today as BlackBerry and Mobileye rally on platform milestones, while NVIDIA d...
Futures markets push the S&P 500 above 7,500 as renewed Iran Strait optimism reduces oil pressure. Analysts warn the ...